Zinterol
Zinterol is a beta-adrenergic agonist.[1]
|  | |
| Names | |
|---|---|
| IUPAC name N-[5-[2-[(1,1-dimethyl-2-phenylethyl)amino]-1-hydroxyethyl]-2-hydroxyphenyl]methanesulfonamide | |
| Identifiers | |
| 3D model (JSmol) | |
| ChEMBL | |
| ChemSpider | |
| ECHA InfoCard | 100.189.867 | 
| MeSH | Zinterol | 
| PubChem CID | |
| UNII | |
| 
 | |
| 
 | |
| Properties | |
| C19H26N2O4S | |
| Molar mass | 378.49 g/mol | 
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references | |
Its structure is based on soterenol (antiarrhythmic) and phentermine.
References
    
- Heubach JF, Graf EM, Molenaar P, et al. (May 2001). "Murine ventricular L-type Ca2+ current is enhanced by zinterol via β1-adrenoceptors, and is reduced in TG4 mice overexpressing the human β2-adrenoceptor". Br. J. Pharmacol. 133 (1): 73–82. doi:10.1038/sj.bjp.0704045. PMC 1572761. PMID 11325796.
    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

